BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19099279)

  • 1. A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.
    Dymalla S; Scheffner M; Weber E; Sehr P; Lohrey C; Hoppe-Seyler F; Hoppe-Seyler K
    J Mol Med (Berl); 2009 Mar; 87(3):321-31. PubMed ID: 19099279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.
    Zanier K; Stutz C; Kintscher S; Reinz E; Sehr P; Bulkescher J; Hoppe-Seyler K; Travé G; Hoppe-Seyler F
    PLoS One; 2014; 9(11):e112514. PubMed ID: 25383876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting.
    Griffin H; Elston R; Jackson D; Ansell K; Coleman M; Winter G; Doorbar J
    J Mol Biol; 2006 Jan; 355(3):360-78. PubMed ID: 16324714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
    Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
    Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
    Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
    Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
    J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
    Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
    Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells.
    Sun P; Dong L; MacDonald AI; Akbari S; Edward M; Hodgins MB; Johnstone SR; Graham SV
    Viruses; 2015 Oct; 7(10):5243-56. PubMed ID: 26445057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.
    Sun L; Zhang G; Li Z; Lei T; Huang C; Song T; Si L
    J Int Med Res; 2008; 36(5):1015-21. PubMed ID: 18831896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.
    Butz K; Denk C; Ullmann A; Scheffner M; Hoppe-Seyler F
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6693-7. PubMed ID: 10829072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.
    Nakagawa S; Huibregtse JM
    Mol Cell Biol; 2000 Nov; 20(21):8244-53. PubMed ID: 11027293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C33-A cells transfected with E6*I or E6*II the short forms of HPV-16 E6, displayed opposite effects on cisplatin-induced apoptosis.
    Vaisman CE; Del Moral-Hernandez O; Moreno-Campuzano S; Aréchaga-Ocampo E; Bonilla-Moreno R; Garcia-Aguiar I; Cedillo-Barron L; Berumen J; Nava P; Villegas-Sepúlveda N
    Virus Res; 2018 Mar; 247():94-101. PubMed ID: 29452161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.